Skip to main content

Table 3 Unwanted effects of bitter melon and glibenclamide observed during the study period

From: Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

 

Group I (n= 30)

Group II (n= 31)

Group III (n= 29)

Gastrointestinal tract

Hyperacidity/Heart burn

3 (9.3)

5 (15.1)

1 (3.4)

Anorexia

5 (16.6)

5 (15.1)

3 (10.3)

Nausea

2 (6.6)

3 (9.6)

1 (3.4)

Diarrhoea

1 (3.3)

2 (6.4)

-

Appetite

2 (6.6)

5 (16.1)

3 (10.3)

Abdominal discomfort

1 (3.3)

1 (3.2)

-

Central Nervous System

Headache

4 (13.3)

9 (29)

5 (17.2)

Dizziness

2 (6.6)

1 (3.20

2 (6.8)

Dermatological

Skin rashes

-

2 (6.4)

1 (3.4)